Can a drug be both misbranded and adulterated at the same time?

A drug can indeed be both misbranded and adulterated at the same time. Misbranding typically refers to false or misleading labeling that does not accurately represent the product or its uses, while adulteration involves issues related to the quality or purity of a drug, such as contamination or the inclusion of harmful substances.

For instance, a medication could have a label that incorrectly states its dosage or expiration date, which would classify it as misbranded. At the same time, if this medication were to contain an unsafe level of a contaminant, it would also be considered adulterated. The statutes governing drug safety and labeling do not prohibit a drug from falling into both categories. Therefore, it is entirely possible for a product's labeling to fail compliance with legal standards while also not meeting safety or manufacturing quality standards.

This dual classification underlines the importance of both proper labeling and maintaining the integrity of drug formulations to ensure consumer safety and efficacy of medications.